I Mab Net Worth
I Mab Net Worth Breakdown | IMAB |
I Mab Net Worth Analysis
I Mab's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including I Mab's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of I Mab's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform I Mab's net worth analysis. One common approach is to calculate I Mab's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares I Mab's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing I Mab's net worth. This approach calculates the present value of I Mab's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of I Mab's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate I Mab's net worth. This involves comparing I Mab's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into I Mab's net worth relative to its peers.
Enterprise Value |
|
To determine if I Mab is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding I Mab's net worth research are outlined below:
| I Mab had very high historical volatility over the last 90 days | |
| I Mab has some characteristics of a very speculative penny stock | |
| I Mab has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 27.64 M. Net Loss for the year was (206.77 M) with profit before overhead, payroll, taxes, and interest of 41.59 M. | |
| I Mab currently holds about 3.92 B in cash with (1.3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| I Mab has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: IMAB Stock Drops Amidst Biotech Sector Movements |
I Mab uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in I Mab. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to I Mab's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know I Mab's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as I Mab is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading I Mab backward and forwards among themselves. I Mab's institutional investor refers to the entity that pools money to purchase I Mab's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 63.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 58.4 K | Xtx Topco Ltd | 2024-09-30 | 43 K | Mariner Wealth Advisors Llc | 2024-09-30 | 31.5 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 30.6 K | Barclays Plc | 2024-09-30 | 30.4 K | Geode Capital Management, Llc | 2024-09-30 | 22 K | Susquehanna International Group, Llp | 2024-09-30 | 13.4 K | Millennium Management Llc | 2024-09-30 | 11.3 K | Hillhouse Capital Advisors, Ltd. | 2024-09-30 | 6.9 M | Caligan Partners Lp | 2024-09-30 | 3.5 M |
Follow I Mab's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.74 M.Market Cap |
|
Project I Mab's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.56) | (0.59) | |
| Return On Capital Employed | (0.56) | (0.59) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (0.85) | (0.81) |
When accessing I Mab's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures I Mab's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of I Mab's profitability and make more informed investment decisions.
Please note, the presentation of I Mab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, I Mab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of I Mab's management manipulating its earnings.
Evaluate I Mab's management efficiency
I Mab has return on total asset (ROA) of (0.2925) % which means that it has lost $0.2925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7172) %, meaning that it created substantial loss on money invested by shareholders. I Mab's management efficiency ratios could be used to measure how well I Mab manages its routine affairs as well as how well it operates its assets and liabilities. As of December 12, 2024, Return On Tangible Assets is expected to decline to -0.59. In addition to that, Return On Capital Employed is expected to decline to -0.59. At present, I Mab's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 5.2 B, whereas Non Current Assets Total are forecasted to decline to about 262.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 20.65 | 21.69 | |
| Tangible Book Value Per Share | 20.45 | 21.47 | |
| Enterprise Value Over EBITDA | (0.69) | (0.66) | |
| Price Book Value Ratio | 0.65 | 1.04 | |
| Enterprise Value Multiple | (0.69) | (0.66) | |
| Price Fair Value | 0.65 | 1.04 | |
| Enterprise Value | 838.6 M | 796.7 M |
Evaluating the management effectiveness of I Mab allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The IMAB Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 0.9873 | Revenue 3.5 M | Quarterly Revenue Growth (0.62) | Revenue Per Share 0.043 | Return On Equity (0.72) |
I Mab Earnings per Share Projection vs Actual
I Mab Corporate Management
| Louie MD | Interim Officer | Profile | |
| Richard MBA | COO CFO | Profile | |
| Weiming Tang | Executive Officer | Profile | |
| Jerry Wang | CoFounder Officer | Profile | |
| Cheng Li | Chief Officer | Profile | |
| Skelton Joseph | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.043 | Quarterly Revenue Growth (0.62) | Return On Assets (0.29) | Return On Equity (0.72) |
The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.